CICP4

Across TCGA pan-cancer cohorts, CICP4 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of CICP4’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where CICP4 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CICP4 is over-expressed in tumor, although a few such as STAD show the opposite, repressed pattern.

BLCA, STAD, and KICH are the cancer types where CICP4 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CICP4 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	All	+0.018	.024	4	view →
STAD	Male	IV	−0.025	.037	1	view →
KICH	All	All	+0.008	.035	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

CICP4–BLCA

Open the BLCA breakdown →